The antiangiogenic effect of siRNAs does not depend on the target of the siRNA, or on intraocular administration. Rather, the siRNAs activate TLR3, a cell surface receptor for long viral dsRNAs, and innate immunity.
- Mark E. Kleinman
- Kiyoshi Yamada
- Jayakrishna Ambati